Recruiting Fabry Disease Studies in Salt Lake City
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease....
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
The main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people wi...
About Fabry Disease Clinical Trials in Salt Lake City
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 2 fabry disease clinical trials recruiting participants in Salt Lake City, UTAH. These studies are seeking a combined 34 participants. Research is being sponsored by Chiesi Farmaceutici S.p.A., UniQure Biopharma B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in Salt Lake City — FAQ
Are there fabry disease clinical trials in Salt Lake City?
Yes, there are 2 fabry disease clinical trials currently recruiting in Salt Lake City, UTAH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Salt Lake City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.
Are clinical trials in Salt Lake City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 2 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated March 2, 2026 from ClinicalTrials.gov